Deutsche Bank’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.85M | Buy |
391,677
+4,137
| +1% | +$91.9K | ﹤0.01% | 1097 |
|
|
2025
Q4 | $10M | Buy |
387,540
+1,623
| +0.4% | +$38.6K | ﹤0.01% | 1082 |
|
|
2025
Q3 | $9.95M | Buy |
385,917
+12,113
| +3% | +$298K | ﹤0.01% | 1052 |
|
|
2025
Q2 | $8.93M | Buy |
373,804
+43,226
| +13% | +$1.09M | ﹤0.01% | 1028 |
|
|
2025
Q1 | $8.21M | Buy |
330,578
+96,172
| +41% | +$2.3M | ﹤0.01% | 1064 |
|
|
2024
Q4 | $4.42M | Buy |
234,406
+160,094
| +215% | +$2.81M | ﹤0.01% | 1391 |
|
|
2024
Q3 | $1.12M | Sell |
74,312
-331,194
| -82% | -$5.66M | ﹤0.01% | 2058 |
|
|
2024
Q2 | $11.6M | Buy |
405,506
+95,785
| +31% | +$2.73M | 0.01% | 964 |
|
|
2024
Q1 | $9.05M | Buy |
309,721
+1,947
| +0.6% | +$59.8K | ﹤0.01% | 1062 |
|
|
2023
Q4 | $10.4M | Buy |
307,774
+125,375
| +69% | +$3.67M | 0.01% | 981 |
|
|
2023
Q3 | $5.6M | Sell |
182,399
-51,895
| -22% | -$1.87M | ﹤0.01% | 1004 |
|
|
2023
Q2 | $9.39M | Sell |
234,294
-11,149
| -5% | -$461K | 0.01% | 1006 |
|
|
2023
Q1 | $10M | Buy |
245,443
+9,077
| +4% | +$361K | 0.01% | 970 |
|
|
2022
Q4 | $9.13M | Buy |
236,366
+2,606
| +1% | +$127K | 0.01% | 991 |
|
|
2022
Q3 | $12.4M | Buy |
233,760
+5,696
| +2% | +$317K | 0.01% | 891 |
|
|
2022
Q2 | $13.3M | Sell |
228,064
-15,061
| -6% | -$987K | 0.01% | 899 |
|
|
2022
Q1 | $18.6M | Buy |
243,125
+13,114
| +6% | +$874K | 0.01% | 857 |
|
|
2021
Q4 | $13.8M | Sell |
230,011
-10,233
| -4% | -$564K | 0.01% | 984 |
|
|
2021
Q3 | $13.5M | Sell |
240,244
-34,497
| -13% | -$1.99M | 0.01% | 1031 |
|
|
2021
Q2 | $16.7M | Buy |
274,741
+41,241
| +18% | +$2.61M | 0.01% | 970 |
|
|
2021
Q1 | $16.4M | Sell |
233,500
-33,026
| -12% | -$2.36M | 0.01% | 976 |
|
|
2020
Q4 | $15.9M | Sell |
266,526
-48,401
| -15% | -$2.83M | 0.01% | 862 |
|
|
2020
Q3 | $18.9M | Sell |
314,927
-103,840
| -25% | -$6.03M | 0.01% | 724 |
|
|
2020
Q2 | $22M | Sell |
418,767
-65,619
| -14% | -$2.74M | 0.02% | 667 |
|
|
2020
Q1 | $16.2M | Sell |
484,386
-74,100
| -13% | -$3.08M | 0.01% | 722 |
|
|
2019
Q4 | $25.3M | Buy |
558,486
+251,057
| +82% | +$10.7M | 0.02% | 700 |
|
|
2019
Q3 | $11.7M | Sell |
307,429
-507,759
| -62% | -$20.3M | 0.01% | 1008 |
|
|
2019
Q2 | $35.5M | Sell |
815,188
-19,245
| -2% | -$817K | 0.02% | 715 |
|
|
2019
Q1 | $31.8M | Buy |
834,433
+441,398
| +112% | +$17.2M | 0.02% | 771 |
|
|
2018
Q4 | $16.9M | Sell |
393,035
-123,855
| -24% | -$5.78M | 0.01% | 977 |
|
|
2018
Q3 | $25.4M | Sell |
516,890
-60,057
| -10% | -$2.6M | 0.01% | 997 |
|
|
2018
Q2 | $18.5M | Buy |
576,947
+290,428
| +101% | +$10M | 0.01% | 1235 |
|
|
2018
Q1 | $8.92M | Sell |
286,519
-53,414
| -16% | -$1.9M | ﹤0.01% | 1721 |
|
|
2017
Q4 | $15.5M | Buy |
339,933
+27,086
| +9% | +$1.07M | 0.01% | 1165 |
|
|
2017
Q3 | $11.7M | Buy |
312,847
+59,235
| +23% | +$2.38M | 0.01% | 1345 |
|
|
2017
Q2 | $12.1M | Buy |
253,612
+173,734
| +217% | +$8.06M | 0.01% | 1261 |
|
|
2017
Q1 | $3.64M | Sell |
79,878
-380,181
| -83% | -$16.4M | ﹤0.01% | 1869 |
|
|
2016
Q4 | $14.9M | Sell |
460,059
-177,592
| -28% | -$5.93M | 0.01% | 1023 |
|
|
2016
Q3 | $21.8M | Buy |
637,651
+335,801
| +111% | +$13.2M | 0.02% | 875 |
|
|
2016
Q2 | $10.2M | Buy |
301,850
+12,832
| +4% | +$631K | 0.01% | 1292 |
|
|
2016
Q1 | $15.3M | Sell |
289,018
-7,214
| -2% | -$422K | 0.01% | 1025 |
|
|
2015
Q4 | $22.7M | Sell |
296,232
-97,710
| -25% | -$5.53M | 0.02% | 864 |
|
|
2015
Q3 | $16.2M | Buy |
393,942
+82,243
| +26% | +$5.04M | 0.01% | 1007 |
|
|
2015
Q2 | $22M | Sell |
311,699
-252,564
| -45% | -$19.9M | 0.01% | 883 |
|
|
2015
Q1 | $50.1M | Buy |
564,263
+171,433
| +44% | +$17.4M | 0.03% | 538 |
|
|
2014
Q4 | $34.8M | Sell |
392,830
-19,873
| -5% | -$1.88M | 0.02% | 732 |
|
|
2014
Q3 | $40M | Sell |
412,703
-46,419
| -10% | -$4.52M | 0.03% | 626 |
|
|
2014
Q2 | $42.2M | Sell |
459,122
-68,615
| -13% | -$5.22M | 0.03% | 594 |
|
|
2014
Q1 | $36.9M | Buy |
527,737
+8,359
| +2% | +$569K | 0.03% | 638 |
|
|
2013
Q4 | $29.9M | Buy |
519,378
+145,946
| +39% | +$7.67M | 0.02% | 706 |
|
|
2013
Q3 | $18M | Buy |
373,432
+15,087
| +4% | +$550K | 0.01% | 954 |
|
|
2013
Q2 | $10.4M | Buy |
+358,345
| New | +$10.4M | 0.01% | 1219 |
|
Other funds holding PCRX
DPCM
VPM
VCM
